Focus: Cancer Center Featured Story 2

Filters close
Released: 21-May-2024 10:00 PM EDT
MD Anderson Research Highlights for May 21, 2024
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

   
Released: 21-May-2024 6:05 PM EDT
Nightmares and hallucinations could signal autoimmune disease
UC Davis Health

An increase in nightmares and hallucinations could signal the onset of autoimmune diseases such as lupus, according to a new study.

Newswise: Skin-Saving Solutions: The Power of Radiotherapy for Treating Skin Cancers
Released: 21-May-2024 10:05 AM EDT
Skin-Saving Solutions: The Power of Radiotherapy for Treating Skin Cancers
Rutgers Cancer Institute

Skin Brachytherapy, also called radiation seed therapy, offers a non-invasive radiation therapy solution to complement or replace surgery for certain skin cancers. Rajesh V. Iyer, MD, is a radiation oncologist at RWJBarnabas Health and chairman of radiation oncology at Community Medical Center, shares more about this treatment option for patients.

Newswise: Oncology Events in Poland Solidify Collaboration with NCCN
Released: 21-May-2024 9:00 AM EDT
Oncology Events in Poland Solidify Collaboration with NCCN
National Comprehensive Cancer Network® (NCCN®)

The National Comprehensive Cancer Network participates in meetings hosted by Maria Sklodowska-Curie National Research Institute of Oncology, the Polish Oncological Society, and Alliance for Innovation to advance work adapting proven cancer treatment guidelines for Poland.

Newswise: NCCN Publishes New Resource for Patients with Intestinal Cancer Type Most Have Never Heard of Before Diagnosis
Released: 20-May-2024 8:30 AM EDT
NCCN Publishes New Resource for Patients with Intestinal Cancer Type Most Have Never Heard of Before Diagnosis
National Comprehensive Cancer Network® (NCCN®)

The NCCN Guidelines for Patients: Small Bowel Adenocarcinoma are now available for free download at NCCN.org/patientguidelines, thanks to funding from the NCCN Foundation®.

Released: 16-May-2024 11:05 AM EDT
Oncologists should re-evaluate cancer treatments near end of life
Yale Cancer Center/Smilow Cancer Hospital

The study, which joins a growing body of research on end-of-life cancer treatment, published May 16 in JAMA Oncology.

Newswise: End-of-life systemic treatment for patients with advanced cancers does not improve survival
15-May-2024 12:05 PM EDT
End-of-life systemic treatment for patients with advanced cancers does not improve survival
University of Texas MD Anderson Cancer Center

Patients with very advanced solid tumors saw no significant improvement in overall survival after receiving systemic therapy, according to a study published today in JAMA Oncology by researchers at The University of Texas MD Anderson Cancer Center and Yale Cancer Center.

Newswise: Dr. Daniel Geynisman Named New Editor-in-Chief for JNCCN—Journal of the National Comprehensive Cancer Network
Released: 16-May-2024 9:00 AM EDT
Dr. Daniel Geynisman Named New Editor-in-Chief for JNCCN—Journal of the National Comprehensive Cancer Network
National Comprehensive Cancer Network® (NCCN®)

Daniel M. Geynisman, MD, is being announced the new Editor-in-Chief for JNCCN—Journal of the National Comprehensive Cancer Network. Dr. Geynisman, Chief of the Division of Genitourinary Medical Oncology at Fox Chase Cancer Center, has a long history of working with NCCN in a variety of roles.

Newswise: Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer
14-May-2024 5:00 PM EDT
Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer
University of Texas MD Anderson Cancer Center

Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery – significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell lung cancer (NSCLC), according to researchers from The University of Texas MD Anderson Cancer Center.

Released: 14-May-2024 1:05 PM EDT
NIH renews COBRE grant for Kansas Institute for Precision Medicine
University of Kansas Cancer Center

The Kansas Institute for Precision Medicine (KIPM) will continue its mission to improve health care by training physicians and scientists in precision medicine and supporting their research, thanks to a renewed Centers of Biomedical Research Excellence (COBRE) award from the National Institute of General Medical Sciences, part of the National Institutes of Health.

Released: 13-May-2024 3:05 PM EDT
Herpes cure with gene editing makes progress in laboratory studies
Fred Hutchinson Cancer Center

Researchers at Fred Hutch Cancer Center have found in pre-clinical studies that an experimental gene therapy for genital and oral herpes removed 90% or more of the infection and suppressed how much virus can be released from an infected individual, which suggests that the therapy would also reduce the spread of the virus.

Released: 13-May-2024 12:05 PM EDT
New Research and Treatment Advances From Yale Cancer Center to Be Presented at the World’s Largest Cancer Research Conference
Yale Cancer Center/Smilow Cancer Hospital

Nearly 50 presentations by researchers and clinicians from Yale Cancer Center (YCC) at Yale School of Medicine will be among the more than 5,000 abstracts available during the annual meeting of the American Society of Clinical Oncology (ASCO) May 31 to June 4 in Chicago, Ill.

Released: 13-May-2024 11:05 AM EDT
New Research and Treatment Advances From Yale Cancer Center to be Presented at the World’s Largest Cancer Research Conference
Yale Cancer Center/Smilow Cancer Hospital

Nearly 50 presentations by researchers and clinicians from Yale Cancer Center (YCC) at Yale School of Medicine will be among the more than 5,000 abstracts available during the annual meeting of the American Society of Clinical Oncology (ASCO) May 31 to June 4 in Chicago, Ill. This year's meeting, themed “The Art and Science of Cancer Care: From Comfort to Cure” will include over 200 sessions.

Newswise: Memorial Sloan Kettering Celebrates Exceptional Service in Nursing: 2024 Robbins Family Awards
Released: 10-May-2024 12:05 PM EDT
Memorial Sloan Kettering Celebrates Exceptional Service in Nursing: 2024 Robbins Family Awards
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) and the Robbins Family Foundation proudly announce that eight distinguished MSK nurses and one nursing team were honored with the 2024 Robbins Family Award for Nursing Excellence. The awards coincide with National Nurses Week (May 6 – 12).

Released: 8-May-2024 12:00 PM EDT
MD Anderson Research Highlights for May 8, 2024
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

   
Newswise: Honoring Oncology Nurses at the State’s Only NCI-designated Comprehensive Cancer Center
7-May-2024 2:05 PM EDT
Honoring Oncology Nurses at the State’s Only NCI-designated Comprehensive Cancer Center
Rutgers Cancer Institute

Three nurses have been named recipients of Rutgers Cancer Institute’s ‘Oncology Nursing Excellence Awards’ during Nurses Week this year. This year’s award recipients were named during the annual Elizabeth Gibby Osborne Lecture.

Released: 7-May-2024 4:05 PM EDT
Yale Cancer Center Earns International Reaccreditation for Expertise in CAR T-cell Therapy and Stem Cell Transplantation
Yale Cancer Center/Smilow Cancer Hospital

Yale Cancer Center (YCC) and Smilow Cancer Hospital (SCH) have again received an internationally recognized accreditation for cellular therapy and stem cell transplantation from the Foundation for the Accreditation of Cellular Therapy (FACT), giving patients life-saving cancer treatment options in Connecticut.

Newswise: Cancer Prevention and Screening is Crucial to Women’s Health
Released: 7-May-2024 2:05 PM EDT
Cancer Prevention and Screening is Crucial to Women’s Health
Rutgers Cancer Institute

Ruth D. Stephenson, DO, FACOG, gynecologic oncologist in the Gynecologic Oncology Program at Rutgers Cancer Institute of New Jersey and RWJBarnabas Health shares tips for women to live their healthiest lives.

Newswise: AI predicts tumor-killing cells with high accuracy
Released: 7-May-2024 10:05 AM EDT
AI predicts tumor-killing cells with high accuracy
Ludwig Cancer Research

Using artificial intelligence, Ludwig Cancer Research scientists have developed a powerful predictive model for identifying the most potent cancer killing immune cells for use in cancer immunotherapies.

   
Newswise: NCCN Policy Summit Encourages Conversation and Action on Sexual Health and Fertility Issues Faced by People with Cancer
Released: 6-May-2024 2:00 PM EDT
NCCN Policy Summit Encourages Conversation and Action on Sexual Health and Fertility Issues Faced by People with Cancer
National Comprehensive Cancer Network® (NCCN®)

The National Comprehensive Cancer Network (NCCN)—an alliance of leading cancer centers—hosts an oncology policy summit focused on how sexual and reproductive health can impact people with cancer before, during, and after treatment.

Released: 6-May-2024 11:30 AM EDT
Dana-Farber review article examines past and guides future efforts to reduce cancer disparities
Dana-Farber Cancer Institute

Investigators at Dana-Farber Cancer Institute have examined the historical evolution of Community Outreach and Engagement initiatives at both the National Cancer Institute (NCI) and National Cancer Institute-Designated Cancer Centers (NCI-DCCs).

Newswise: Sharing the Wealth
Released: 6-May-2024 11:05 AM EDT
Sharing the Wealth
University of New Mexico Comprehensive Cancer Center

A cancer diagnosis scares most people. Those outside of large population centers like Albuquerque have the additional concern of having to travel to get timely, specialized medical treatment. Now, a new program at The University of New Mexico Comprehensive Cancer Center aims to streamline the process for all New Mexicans, regardless of where they live in the state.

Newswise: Belfer family’s $20 million donation invigorates neurodegeneration research at MD Anderson
Released: 6-May-2024 10:00 AM EDT
Belfer family’s $20 million donation invigorates neurodegeneration research at MD Anderson
University of Texas MD Anderson Cancer Center

Laurence Belfer, on behalf of Robert Belfer and the Belfer family, today announced a $20 million gift to The University of Texas MD Anderson Cancer Center to strengthen neurodegeneration research through the Belfer Neurodegeneration Consortium (BNDC), a transformative multi-institutional initiative to advance the study and treatment of Alzheimer’s disease.

Released: 6-May-2024 9:05 AM EDT
Study Uncovers At Least One Cause of Roadblocks to Cancer Immunotherapy
Yale Cancer Center/Smilow Cancer Hospital

A study led by Yale scientists, published April 25 in the journal Science Immunology, investigated the potential causes associated with T cell exclusion using a genome-wide screen of more than 1,000 human proteins.

Released: 6-May-2024 9:05 AM EDT
Memorial Sloan Kettering Cancer Center Launches Innovative Projects to Improve Health in Queens and Brooklyn
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) today announced an innovative set of initiatives to support underserved communities in New York City who lack access to cancer screening and early detection. With critical support from longtime MSK Board Member Bruce Ratner, the Ratner Early Detection Initiative (REDI) draws from MSK’s deep experience in cancer science and discovery, community engagement, and compassionate patient care.

Newswise: Tennis greats Chris Evert and Martina Navratilova honored at A Conversation With a Living Legend®
Released: 3-May-2024 3:00 PM EDT
Tennis greats Chris Evert and Martina Navratilova honored at A Conversation With a Living Legend®
University of Texas MD Anderson Cancer Center

Cancer survivors and tennis legends Chris Evert and Martina Navratilova participated in a fireside-style chat with Robin Roberts on Wednesday, May 1, at The University of Texas MD Anderson Cancer Center’s signature event, A Conversation with a Living Legend ®, hosted at the Post Oak Hotel at Uptown Houston.

Newswise: Metastatic Prostate Cancer Research: PSMAfore follow-on study favors radioligand therapy over change to androgen receptor pathway inhibition
Released: 3-May-2024 12:00 PM EDT
Metastatic Prostate Cancer Research: PSMAfore follow-on study favors radioligand therapy over change to androgen receptor pathway inhibition
Dana-Farber Cancer Institute

Follow-on analysis of results from the phase 3 PSMAfore study, along with the overall study results, support the consideration of 177Lu-PSMA-617 as a new standard treatment approach for this prevalent population of patients with mCRPC. Research led by Dana-Farber Cancer Institute and others.

Released: 2-May-2024 4:05 PM EDT
Coping in the aftermath of a cancer diagnosis
Fred Hutchinson Cancer Center

Receiving a cancer diagnosis can be one of the most stressful, pivotal moments in an individual’s life. With May being Mental Health Awareness Month, Fred Hutch social psychologist and researcher Megan J. Shen, PhD, shares tips for coping with a cancer diagnosis and how patients and their caregivers can navigate appointments with their oncologists.

Newswise: Increasing doses of varenicline or nicotine replacement helps persistent smokers quit
1-May-2024 10:00 AM EDT
Increasing doses of varenicline or nicotine replacement helps persistent smokers quit
University of Texas MD Anderson Cancer Center

For most smokers, quitting on the first attempt is likely to be unsuccessful, but a new study from The University of Texas MD Anderson Cancer Center found patients were more likely to quit if their cessation regimen was altered and doses were increased. Researchers also found that varenicline, a cessation medication, was more effective than combined nicotine replacement therapy (CNRT), such as patches or lozenges.

   
Released: 1-May-2024 5:05 PM EDT
Study finds biomarkers for psychiatric symptoms in patients with rare genetic condition 22q
UC Davis MIND Institute

A new UC Davis study finds biomarkers that could identify patients with 22q11.2 deletion syndrome who are more likely to develop schizophrenia.

Newswise: MD Anderson researcher Sharon Dent elected to prestigious National Academy of Sciences
Released: 1-May-2024 3:00 PM EDT
MD Anderson researcher Sharon Dent elected to prestigious National Academy of Sciences
University of Texas MD Anderson Cancer Center

Sharon Dent, Ph.D., professor of Epigenetics and Molecular Carcinogenesis at The University of Texas MD Anderson Cancer Center, has been elected to the National Academy of Sciences (NAS). Dent is a global leader in the field of chromatin research whose foundational work has helped define the role of chromatin in cancer growth and development.

   
Newswise: 109 Yale Cancer Center and Smilow Cancer Hospital physicians recognized as ‘Top Doctors’ in Connecticut
Released: 1-May-2024 1:05 PM EDT
109 Yale Cancer Center and Smilow Cancer Hospital physicians recognized as ‘Top Doctors’ in Connecticut
Yale Cancer Center/Smilow Cancer Hospital

Connecticut Magazine released its “Top Doctors” issue today, listing some of the state’s best physicians, who provide exceptional care for patients. This year’s list includes 109 Yale Cancer Center (YCC) and Smilow Cancer Hospital (SCH) physicians, a 35% increase in “Top Doctors” for SCH and YCC from last year.

Newswise: Resource-Appropriate Cancer Care, Including Coexisting Health Issues of HIV and Cancer, to be Addressed During Meeting in Nairobi
Released: 1-May-2024 8:55 AM EDT
Resource-Appropriate Cancer Care, Including Coexisting Health Issues of HIV and Cancer, to be Addressed During Meeting in Nairobi
National Comprehensive Cancer Network® (NCCN®)

International collaboration to improve cancer outcomes in Sub-Saharan Africa is working to update consensus harmonized guidelines on several key subjects in oncology, including how best to treat people with both cancer and HIV.

Newswise: MD Anderson and Pan American Health Organization join forces to support cancer prevention and control in the Americas
Released: 1-May-2024 8:05 AM EDT
MD Anderson and Pan American Health Organization join forces to support cancer prevention and control in the Americas
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center and the Pan American Health Organization (PAHO) today announced the signing of an agreement to strengthen cancer prevention and control initiatives across the Americas. The event took place in Washington, D.C., with leaders from both organizations.

Released: 30-Apr-2024 10:05 AM EDT
Moffitt Initiates Groundbreaking Clinical Trial with Oncolytic Virus for Non-Small Cell Lung Cancer
Moffitt Cancer Center

Moffitt Cancer Center has launched a pioneering clinical trial for patients with late-stage non-small cell lung cancer whose disease has progressed following initial frontline standard of care immunotherapy that includes an immune checkpoint inhibitor alone or combined with chemotherapy.

Released: 30-Apr-2024 7:00 AM EDT
MD Anderson and Replay announce FDA clearance of IND application for first-in-class PRAME-targeted TCR NK cell therapy for hematological malignancies
University of Texas MD Anderson Cancer Center

MD Anderson and Replay today announced that the Food & Drug Administration (FDA) has issued a ‘safe to proceed’ for the Investigational New Drug (IND) application for PRAME TCR/IL-15 NK (SY-307), an engineered T cell receptor natural killer (TCR NK) cell therapy for relapsed/refractory myeloid malignancies.

Newswise: Cancer screening rates are significantly lower in US Federally Qualified Health Centers
Released: 29-Apr-2024 11:05 AM EDT
Cancer screening rates are significantly lower in US Federally Qualified Health Centers
University of New Mexico Comprehensive Cancer Center

A national study led by researchers at The University of Texas MD Anderson Cancer Center and The University of New Mexico (UNM) Comprehensive Cancer Center found major gaps in breast, cervical and colorectal cancer screening use in Federally Qualified Health Centers (FQHCs) in the US, relative to overall screening rates in the country.

Newswise: Cancer screening rates are significantly lower in U.S. Federally Qualified Health Centers
26-Apr-2024 4:00 PM EDT
Cancer screening rates are significantly lower in U.S. Federally Qualified Health Centers
University of Texas MD Anderson Cancer Center

A national study led by researchers at The University of Texas MD Anderson Cancer Center and The University of New Mexico (UNM) Comprehensive Cancer Center found major gaps in breast, cervical and colorectal cancer screening use in Federally Qualified Health Centers (FQHCs) in the U.S., relative to overall screening rates in the country.

Released: 26-Apr-2024 6:05 PM EDT
1 in 5 milk samples from grocery stores test positive for bird flu. Why the FDA says it’s still safe to drink
UC Davis Health

The FDA announced 1 in 5 grocery store milk samples tested positive for bird flu. UC Davis experts explain the limits of the test and how to protect yourself from avian influenza.

Newswise: MD Anderson and RUSH Unveil RUSH MD Anderson Cancer Center
26-Apr-2024 11:00 AM EDT
MD Anderson and RUSH Unveil RUSH MD Anderson Cancer Center
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center and RUSH University System for Health today announced a partnership to create RUSH MD Anderson Cancer Center.

Newswise: Rutgers Cancer Institute of New Jersey Researcher Elected to the American Academy of Arts and Sciences
Released: 26-Apr-2024 9:05 AM EDT
Rutgers Cancer Institute of New Jersey Researcher Elected to the American Academy of Arts and Sciences
Rutgers Cancer Institute

RWJBarnabas Health and Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, have announced that Eileen White, PhD, Deputy Director and Chief Scientific Officer at Rutgers Cancer Institute, has been elected as a member of the American Academy of Arts and Sciences.

Newswise: Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital's Transplant and Cell Therapy
Released: 25-Apr-2024 10:05 AM EDT
Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital's Transplant and Cell Therapy
Rutgers Cancer Institute

The Foundation for the Accreditation of Cellular Therapy (FACT) has once again awarded Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital’s (RWJUH) Transplant and Cell Therapy Program accreditation under the FACT-JACIE International Standards for Hematopoietic Cellular Therapy

Released: 24-Apr-2024 1:05 PM EDT
Moffitt Study Suggests Cells Possess Hidden Communication System
Moffitt Cancer Center

Cells constantly navigate a dynamic environment, facing ever-changing conditions and challenges. But how do cells swiftly adapt to these environmental fluctuations? A new Moffitt Cancer Center study, published in iScience, is answering that question by challenging our understanding of how cells function. A team of researchers suggests that cells possess a previously unknown information processing system that allows them to make rapid decisions independent of their genes.

Released: 24-Apr-2024 12:00 PM EDT
MD Anderson Research Highlights for April 24, 2024
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

   
Newswise: Ludwig Lausanne scientists identify and show how to target a key tumor defense against immune attack
Released: 24-Apr-2024 11:05 AM EDT
Ludwig Lausanne scientists identify and show how to target a key tumor defense against immune attack
Ludwig Cancer Research

A Ludwig Cancer Research study has discovered how a lipid molecule found at high levels within tumors undermines the anti-cancer immune response and compromises a recently approved immunotherapy known as adoptive cell therapy (ACT) using tumor infiltrating lymphocytes, or TIL-ACT.



close
2.54967